i-SENS Inc Asset Resilience Ratio
i-SENS Inc asset resilience ratio. i-SENS Inc (099190) has an Asset Resilience Ratio of 8.59% as of March 2026. The Asset Resilience Ratio measures the percentage of a company's total assets that are held in liquid form (cash and short-term investments). This metric indicates how well-positioned the company is to handle unexpected financial challenges, economic downturns, or strategic opportunities without requiring external financing. See 099190 defensive asset coverage days to measure how many days the company can operate on defensive assets alone.
Liquid Assets
Total Assets
Resilience Assessment
Asset Resilience Ratio of i-SENS Inc (2012–2025)
Asset resilience ratio of i-SENS Inc from 2012 to 2025. This chart shows how i-SENS Inc's Asset Resilience Ratio has changed over time. Read 099190 current and long-term liabilities for a breakdown of total debt and financial obligations.
Liquid Assets Composition Over Time
This chart breaks down i-SENS Inc's liquid assets into cash & equivalents and short-term investments, showing how the composition has evolved over time. For the complete balance sheet picture, see total assets of i-SENS Inc.
Current Liquid Assets Breakdown
| Component | Amount | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₩0.00 | 0% |
| Short-term Investments | ₩50.77 Billion | 8.59% |
| Total Liquid Assets | ₩50.77 Billion | 8.59% |
Asset Resilience Insights
- Limited Liquidity: i-SENS Inc maintains only 8.59% of assets in liquid form.
- This low level may indicate efficient asset utilization but could pose risks during economic downturns.
- The company has significant short-term investments, indicating active treasury management.
i-SENS Inc Industry Peers by Asset Resilience Ratio
Compare i-SENS Inc's asset resilience ratio with other companies in the same industry.
| Company | Industry | Asset Resilience Ratio |
|---|---|---|
|
Elbit Med Tech
TA:EMTC |
Healthcare Equipment & Supplies | 7.83% |
|
InBody Co.Ltd
KQ:041830 |
Healthcare Equipment & Supplies | 20.98% |
|
INFINITT Healthcare Co. Ltd
KQ:071200 |
Healthcare Equipment & Supplies | 61.76% |
|
Value Added Technology Co. Ltd
KQ:043150 |
Healthcare Equipment & Supplies | 3.34% |
|
Sewoon Medical Co. Ltd
KQ:100700 |
Healthcare Equipment & Supplies | 11.84% |
|
Meta Biomed Co. Ltd
KQ:059210 |
Healthcare Equipment & Supplies | 11.86% |
|
MEDIANA Co.Ltd
KQ:041920 |
Healthcare Equipment & Supplies | 39.47% |
|
CU Medical Systems Inc
KQ:115480 |
Healthcare Equipment & Supplies | 6.84% |
i-SENS Inc Asset Resilience Ratio by Year (2012–2025)
i-SENS Inc asset resilience ratio by year from 2012 to 2025. The table below shows the annual Asset Resilience Ratio data for i-SENS Inc.
| Year | Asset Resilience Ratio (%) | Liquid Assets | Total Assets | Change |
|---|---|---|---|---|
| 2025-12-31 | 9.21% | ₩53.18 Billion ≈ $36.04 Million |
₩577.66 Billion ≈ $391.47 Million |
-10.96pp |
| 2024-12-31 | 20.16% | ₩119.13 Billion ≈ $80.73 Million |
₩590.87 Billion ≈ $400.42 Million |
+9.76pp |
| 2023-12-31 | 10.40% | ₩51.87 Billion ≈ $35.15 Million |
₩498.82 Billion ≈ $338.04 Million |
-5.73pp |
| 2022-12-31 | 16.13% | ₩72.51 Billion ≈ $49.14 Million |
₩449.57 Billion ≈ $304.67 Million |
-7.33pp |
| 2021-12-31 | 23.45% | ₩100.66 Billion ≈ $68.22 Million |
₩429.18 Billion ≈ $290.85 Million |
-3.07pp |
| 2020-12-31 | 26.52% | ₩81.43 Billion ≈ $55.19 Million |
₩307.03 Billion ≈ $208.07 Million |
+9.35pp |
| 2019-12-31 | 17.18% | ₩46.38 Billion ≈ $31.43 Million |
₩270.04 Billion ≈ $183.00 Million |
+6.06pp |
| 2018-12-31 | 11.11% | ₩28.01 Billion ≈ $18.98 Million |
₩252.05 Billion ≈ $170.81 Million |
-0.83pp |
| 2017-12-31 | 11.95% | ₩27.96 Billion ≈ $18.95 Million |
₩234.08 Billion ≈ $158.63 Million |
-0.93pp |
| 2016-12-31 | 12.88% | ₩27.70 Billion ≈ $18.77 Million |
₩215.07 Billion ≈ $145.75 Million |
+9.54pp |
| 2015-12-31 | 3.34% | ₩6.00 Billion ≈ $4.07 Million |
₩179.80 Billion ≈ $121.85 Million |
+1.94pp |
| 2014-12-31 | 1.40% | ₩2.28 Billion ≈ $1.55 Million |
₩163.51 Billion ≈ $110.81 Million |
-3.88pp |
| 2013-12-31 | 5.28% | ₩7.46 Billion ≈ $5.06 Million |
₩141.41 Billion ≈ $95.83 Million |
+3.80pp |
| 2012-12-31 | 1.48% | ₩1.36 Billion ≈ $920.79K |
₩92.05 Billion ≈ $62.38 Million |
-- |
About i-SENS Inc
i-SENS, Inc. provides diagnostic biosensors in South Korea. The company offers point of care testing devices, such as HbA1c, blood gas, electrolyte, and PT/INR analyzers; CareSens blood glucose monitoring systems; and lancing and other ancillary devices, as well as diabetes management services. It exports its products to approximately 110 countries, including the United States, Japan, and Europe.… Read more